Jun Hayakawa

4.2k total citations
115 papers, 3.5k citations indexed

About

Jun Hayakawa is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Jun Hayakawa has authored 115 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 18 papers in Physiology and 17 papers in Oncology. Recurrent topics in Jun Hayakawa's work include Immunotherapy and Immune Responses (9 papers), Estrogen and related hormone effects (7 papers) and Virus-based gene therapy research (7 papers). Jun Hayakawa is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Estrogen and related hormone effects (7 papers) and Virus-based gene therapy research (7 papers). Jun Hayakawa collaborates with scholars based in Japan, United States and Canada. Jun Hayakawa's co-authors include Masahide Ohmichi, Yuji Murata, Keiichi Tasaka, Tetsuo Shiohara, Hirohisa Kurachi, Koji Hisamoto, Yukihiro Nishio, Dan Mercola, Kazushige Adachi and Yuki Kanda and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Blood.

In The Last Decade

Jun Hayakawa

107 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Hayakawa Japan 32 1.7k 516 496 490 422 115 3.5k
Yusuke Kobayashi Japan 31 1.3k 0.8× 532 1.0× 280 0.6× 525 1.1× 203 0.5× 232 3.4k
Pnina Fishman Israel 44 1.7k 1.0× 773 1.5× 221 0.4× 1.1k 2.2× 278 0.7× 161 4.9k
Shohei Yamashina Japan 35 1.6k 0.9× 274 0.5× 532 1.1× 265 0.5× 542 1.3× 161 4.1k
Anna Batistatou Greece 35 2.0k 1.2× 1.1k 2.2× 225 0.5× 365 0.7× 253 0.6× 201 4.5k
Igor Buchwalow Germany 27 1.1k 0.7× 331 0.6× 142 0.3× 530 1.1× 493 1.2× 126 2.7k
Robin Plevin United Kingdom 44 3.2k 1.9× 611 1.2× 252 0.5× 1.2k 2.5× 800 1.9× 149 7.3k
Ilona Linnoila United States 26 1.9k 1.1× 868 1.7× 172 0.3× 638 1.3× 207 0.5× 46 3.4k
Kirk M. Druey United States 37 2.8k 1.6× 603 1.2× 403 0.8× 769 1.6× 553 1.3× 98 5.2k
Carlos D. Figueroa Chile 29 1.4k 0.8× 434 0.8× 310 0.6× 801 1.6× 333 0.8× 93 4.1k
Satoshi Matsuda Japan 32 2.4k 1.4× 642 1.2× 179 0.4× 1.7k 3.5× 296 0.7× 72 5.0k

Countries citing papers authored by Jun Hayakawa

Since Specialization
Citations

This map shows the geographic impact of Jun Hayakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Hayakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Hayakawa more than expected).

Fields of papers citing papers by Jun Hayakawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Hayakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Hayakawa. The network helps show where Jun Hayakawa may publish in the future.

Co-authorship network of co-authors of Jun Hayakawa

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Hayakawa. A scholar is included among the top collaborators of Jun Hayakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Hayakawa. Jun Hayakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kano, Yoko, et al.. (2018). Two Cases of Acute Febrile Neutrophilic Dermatosis Thought to be Caused by Topical Clindamycin. Acta Dermato Venereologica. 99(2). 228–229. 2 indexed citations
2.
Hayakawa, Jun, Takahiro Ueda, Yusuke Fujiwara, et al.. (2013). Successful coil embolization for life‐threatening hemorrhage in childhood leukemia induction therapy. Pediatrics International. 55(2). 248–251. 2 indexed citations
3.
Fukazawa, Ryuji, et al.. (2011). Serum KL‐6 and surfactant protein D in children with 2009 pandemic H1N1 influenza infection. Pediatrics International. 53(6). 910–914. 4 indexed citations
4.
Nagase, Hiroshi, Kuniaki Kawamura, Koji Kawai, & Jun Hayakawa. (2010). Discovery of the First in Class Drug for Intractable Itch, Nalfurafine Hydrochloride. Journal of Synthetic Organic Chemistry Japan. 68(12). 1261–1271.
5.
Hayakawa, Jun, et al.. (2010). 5% Dimethyl sulfoxide (DMSO) and pentastarch improves cryopreservation of cord blood cells over 10% DMSO. Transfusion. 50(10). 2158–2166. 35 indexed citations
6.
Hayakawa, Jun, Osamu Fujino, Mutsumi Murakami, & Yoshitaka Fukunaga. (2007). Unusual findings in single‐photon emission computed tomography in a 1‐year‐old boy with acute necrotizing encephalopathy. Pediatrics International. 49(1). 94–96. 1 indexed citations
7.
Wang, Yipeng, Jun Hayakawa, Fred Long, et al.. (2005). “Promoter Array” Studies Identify Cohorts of Genes Directly Regulated by Methylation, Copy Number Change, or Transcription Factor Binding in Human Cancer Cells. Annals of the New York Academy of Sciences. 1058(1). 162–185. 20 indexed citations
8.
Ohmichi, Masahide, Jun Hayakawa, Keiichi Tasaka, Hirohisa Kurachi, & Yuji Murata. (2005). Mechanisms of platinum drug resistance. Trends in Pharmacological Sciences. 26(3). 113–116. 134 indexed citations
9.
Hayakawa, Jun, Shalu Mittal, Kemal Korkmaz, et al.. (2005). Identification of Promoters Bound by c-Jun/ATF2 during Rapid Large-Scale Gene Activation following Genotoxic Stress. Molecular Cell. 17(1). 161–161. 3 indexed citations
10.
Asano, Takeshi, et al.. (2003). Analysis of Resistance-Related Gene Expression in Doxorubicin-Resistant Leukemia Cell Line by DNA Microarray. 17(5). 340–345. 2 indexed citations
11.
Takahashi, Ryo, Yoshiko Mizukawa, Yoshimi Yamazaki, et al.. (2003). In Vitro Differentiation from Naive to Mature E-Selectin Binding CD4 T Cells: Acquisition of Skin-Homing Properties Occurs Independently of Cutaneous Lymphocyte Antigen Expression. The Journal of Immunology. 171(11). 5769–5777. 14 indexed citations
12.
Migita, Makoto, et al.. (2003). Home treatment with enzyme replacement therapy in a 5‐year‐old girl with type 2 Gaucher disease. Pediatrics International. 45(3). 363–365. 3 indexed citations
13.
Hayakawa, Jun, Masahide Ohmichi, Keiichi Tasaka, et al.. (2002). Regulation of the PRL Promoter by Akt through cAMP Response Element Binding Protein. Endocrinology. 143(1). 13–22. 41 indexed citations
14.
Yokoi, Takeshi, Masahide Ohmichi, Keiichi Tasaka, et al.. (2000). Activation of the Luteinizing Hormone β Promoter by Gonadotropin-releasing Hormone Requires c-Jun NH2-terminal Protein Kinase. Journal of Biological Chemistry. 275(28). 21639–21647. 78 indexed citations
15.
Hayakawa, Jun, Masahide Ohmichi, Hirohisa Kurachi, et al.. (1999). Inhibition of Extracellular Signal-regulated Protein Kinase or c-Jun N-terminal Protein Kinase Cascade, Differentially Activated by Cisplatin, Sensitizes Human Ovarian Cancer Cell Line. Journal of Biological Chemistry. 274(44). 31648–31654. 160 indexed citations
16.
Hayakawa, Jun, et al.. (1996). Adult Thymus Contains Dendritic Epidermal T Cell Precursors That Home to the Epidermis in Irradiated, but Not in Normal, Mice. Cellular Immunology. 174(2). 190–198. 5 indexed citations
18.
Hayakawa, Jun, et al.. (1989). [Periodic sublingual buprenorphine for pain relief after upper abdominal surgery].. PubMed. 38(4). 493–7. 3 indexed citations
19.
Shiohara, Tetsuo, Jun Hayakawa, & Masaji Nagashima. (1989). Interferon-γ as adjuvant therapy for resistant warts. Journal of the American Academy of Dermatology. 21(2). 387–391. 14 indexed citations
20.
Shiohara, Tetsuo, Jun Hayakawa, & Masaji Nagashima. (1989). Psoriasis and Lichen planus: Coexistence in a Single Patient. Dermatology. 179(4). 178–182. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026